You are here: Welcome » Braden Manns

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
braden_manns [2022/08/02 21:58]
liam [Alberta Kidney Disease Network]
braden_manns [2025/01/09 00:42] (current)
liam
Line 46: Line 46:
 ==== Canadian Society of Nephrology ==== ==== Canadian Society of Nephrology ====
  
-Manns served as President of the [[:Canadian Society of Nephrology]], funded by [[:Alexion]], [[:Amgen]], [[:AstraZeneca]], [[:Bayer]], [[:Boehringer Ingelheim]], [[:Eli Lilly]], [[:Fresenius]], [[:Horizon Therapeutics]], [[:Janssen]], and [[:Otsuka]].((//Our Partners.// CSN/SCN. Retrieved January 8, 2022, from https://archive.ph/Omio2)) ((//HE Braden Manns.// O’Brien Institute for Public Health. Retrieved January 8, 2022, from https://obrieniph.ucalgary.ca/research/centres-programs-research-groups-and-units/health-economics/meet-our-team/dr-braden-manns-0)) +Manns served as President of the [[Canadian Society of Nephrology]], funded by [[pharmaceutical_companies:Alexion]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:Eli Lilly]], [[pharmaceutical_companies:Fresenius]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Horizon Therapeutics]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Otsuka]] and [[pharmaceutical_companies:Pfizer]].((//Our Partners.// CSN/SCN. Retrieved January 8, 2022, from https://archive.ph/Omio2)) ((//HE Braden Manns.// O’Brien Institute for Public Health. Retrieved January 8, 2022, from https://obrieniph.ucalgary.ca/research/centres-programs-research-groups-and-units/health-economics/meet-our-team/dr-braden-manns-0)) ((//Our Partners.// Canadian Society of Nephrology. Retrieved October 22, 2022, from https://web.archive.org/web/20221022180917/https://www.csnscn.ca/our-partners/))
 ==== Kidney Foundation of Canada ==== ==== Kidney Foundation of Canada ====
  
Line 65: Line 64:
 === Interdisciplinary Chronic Disease Collaboration === === Interdisciplinary Chronic Disease Collaboration ===
  
-He also served as co-lead for the University's Interdisciplinary Chronic Disease Collaboration, which was funded by Alberta Innovates (which is partnered with [[:pharmaceutical_companies:Pfizer]].((Brunner, D. (2018, November 26). //Alberta Government and Pfizer Canada boosts provincial collaborative health innovation partnership with Alberta Innovates.// Alberta Innovates. https://archive.ph/1ppaw))+He also served as co-lead for the University's Interdisciplinary Chronic Disease Collaboration, which was funded by Alberta Innovates (which is partnered with [[:pharmaceutical_companies:Pfizer]]).((Brunner, D. (2018, November 26). //Alberta Government and Pfizer Canada boosts provincial collaborative health innovation partnership with Alberta Innovates.// Alberta Innovates. https://archive.ph/1ppaw))
  
 ===== Funding ===== ===== Funding =====
Line 82: Line 81:
 ==== Pharmaceutical Companies ==== ==== Pharmaceutical Companies ====
  
-Manns has received funding via an unrestricted grant from [[:Baxter]].((Trachtenberg, A. J., Quinn, A. E., Ma, Z., Klarenbach, S., Hemmelgarn, B., Tonelli, M., Faris, P., Weaver, R., Au, F., Zhang, J., & Manns, B. (2020). //Association between change in physician remuneration and use of peritoneal dialysis: a population-based cohort analysis.// CMAJ Open, 8(1), E96–E104. https://doi.org/10.9778/cmajo.20190132))+Manns has received funding via an unrestricted grant from [[pharmaceutical_companies:Baxter]].((Trachtenberg, A. J., Quinn, A. E., Ma, Z., Klarenbach, S., Hemmelgarn, B., Tonelli, M., Faris, P., Weaver, R., Au, F., Zhang, J., & Manns, B. (2020). //Association between change in physician remuneration and use of peritoneal dialysis: a population-based cohort analysis.// CMAJ Open, 8(1), E96–E104. https://doi.org/10.9778/cmajo.20190132))
  
 ===== Media Appearances ===== ===== Media Appearances =====
Line 89: Line 88:
  
   * [[https://www.campfire.wiki/lib/exe/fetch.php?media=public_health_agencies:canada:scn_podcast_-_december_2021.mp3|SCN Podcast - December 2021]]((AHS Communications. (2021, December). //SCN Podcast - December 2021.// SoundCloud. https://soundcloud.com/ahs-communications/scn-podcast-december-2021))   * [[https://www.campfire.wiki/lib/exe/fetch.php?media=public_health_agencies:canada:scn_podcast_-_december_2021.mp3|SCN Podcast - December 2021]]((AHS Communications. (2021, December). //SCN Podcast - December 2021.// SoundCloud. https://soundcloud.com/ahs-communications/scn-podcast-december-2021))
 +
 +===== External links =====
 +
 +  * [[https://www.whiteroseintelligence.com/braden-manns/|White Rose Wiki]]
Back to top